Cargando…
The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity
The membrane attack complex of complement (C) in sublytic concentrations stimulates endothelial cells (EC) to express adhesion molecules and to release biologically active products. We have examined the ability of a cytolytically inactive form of this complex, which is incapable of inserting into th...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196305/ https://www.ncbi.nlm.nih.gov/pubmed/9151899 |
_version_ | 1782148035592060928 |
---|---|
author | Tedesco, Francesco Pausa, Mario Nardon, Ermanno Introna, Martino Mantovani, Alberto Dobrina, Aldo |
author_facet | Tedesco, Francesco Pausa, Mario Nardon, Ermanno Introna, Martino Mantovani, Alberto Dobrina, Aldo |
author_sort | Tedesco, Francesco |
collection | PubMed |
description | The membrane attack complex of complement (C) in sublytic concentrations stimulates endothelial cells (EC) to express adhesion molecules and to release biologically active products. We have examined the ability of a cytolytically inactive form of this complex, which is incapable of inserting into the cell membrane, to upregulate the expression of adhesion molecules and of tissue factor (TF) procoagulant activity. The inactive terminal C complex (iTCC) was prepared by mixing C5b6, C7, C8, and C9 and was purified by fast protein liquid chromatography on a Superose 12 column. Binding of this complex to EC was found to be dose dependent and was inhibited by anti-C9 antibodies, as assessed both by ELISA using an mAb anti-C9 neoantigen and by measuring cell-bound (125)I-labeled iTCC. Exposure of EC to iTCC resulted in a dose- and time-dependent expression of endothelial leukocyte adhesion molecule 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 accompanied by increased levels of the corresponding mRNA, but not in the rapid expression of P-selectin. Inactive TCC also induced increased TF activity evaluated by a chromogenic assay that measures the formation of factor Xa. These effects were inhibited by anti-C9 antibodies. The data support the conclusion that iTCC may induce proinflammatory and procoagulant activities on EC. |
format | Text |
id | pubmed-2196305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21963052008-04-16 The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity Tedesco, Francesco Pausa, Mario Nardon, Ermanno Introna, Martino Mantovani, Alberto Dobrina, Aldo J Exp Med Article The membrane attack complex of complement (C) in sublytic concentrations stimulates endothelial cells (EC) to express adhesion molecules and to release biologically active products. We have examined the ability of a cytolytically inactive form of this complex, which is incapable of inserting into the cell membrane, to upregulate the expression of adhesion molecules and of tissue factor (TF) procoagulant activity. The inactive terminal C complex (iTCC) was prepared by mixing C5b6, C7, C8, and C9 and was purified by fast protein liquid chromatography on a Superose 12 column. Binding of this complex to EC was found to be dose dependent and was inhibited by anti-C9 antibodies, as assessed both by ELISA using an mAb anti-C9 neoantigen and by measuring cell-bound (125)I-labeled iTCC. Exposure of EC to iTCC resulted in a dose- and time-dependent expression of endothelial leukocyte adhesion molecule 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 accompanied by increased levels of the corresponding mRNA, but not in the rapid expression of P-selectin. Inactive TCC also induced increased TF activity evaluated by a chromogenic assay that measures the formation of factor Xa. These effects were inhibited by anti-C9 antibodies. The data support the conclusion that iTCC may induce proinflammatory and procoagulant activities on EC. The Rockefeller University Press 1997-05-05 /pmc/articles/PMC2196305/ /pubmed/9151899 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Tedesco, Francesco Pausa, Mario Nardon, Ermanno Introna, Martino Mantovani, Alberto Dobrina, Aldo The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity |
title | The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity |
title_full | The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity |
title_fullStr | The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity |
title_full_unstemmed | The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity |
title_short | The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity |
title_sort | cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196305/ https://www.ncbi.nlm.nih.gov/pubmed/9151899 |
work_keys_str_mv | AT tedescofrancesco thecytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT pausamario thecytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT nardonermanno thecytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT intronamartino thecytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT mantovanialberto thecytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT dobrinaaldo thecytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT tedescofrancesco cytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT pausamario cytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT nardonermanno cytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT intronamartino cytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT mantovanialberto cytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity AT dobrinaaldo cytolyticallyinactiveterminalcomplementcomplexactivatesendothelialcellstoexpressadhesionmoleculesandtissuefactorprocoagulantactivity |